Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	104	10	38	8	18	6	Upgrade
Market Cap Growth	107.82%	-73.09%	395.11%	-57.14%	180.00%	-44.44%	Upgrade
Enterprise Value	103	8	34	6	16	4	Upgrade
Last Close Price	0.05	0.01	0.02	0.01	0.03	0.01	Upgrade
PE Ratio	37.18	-	-	-	-	-	Upgrade
PS Ratio	6.00	1.06	7.18	16.57	8.13	2.74	Upgrade
PB Ratio	15.13	3.10	2.53	-21.05	9.27	2.45	Upgrade
P/TBV Ratio	14.44	2.84	10.66	-	9.92	2.60	Upgrade
P/FCF Ratio	730.81	-	-	-	337.34	438.85	Upgrade
P/OCF Ratio	64.60	-	-	-	337.34	132.68	Upgrade
EV/Sales Ratio	5.92	0.88	6.45	12.19	7.36	1.88	Upgrade
EV/EBITDA Ratio	28.90	-	-	-	-	-	Upgrade
EV/EBIT Ratio	34.84	-	-	-	-	-	Upgrade
EV/FCF Ratio	721.85	-	-	-	305.44	301.53	Upgrade
Debt / Equity Ratio	0.25	0.22	0.04	-1.09	-	0.02	Upgrade
Debt / FCF Ratio	12.19	-	-	-	-	3.25	Upgrade
Asset Turnover	1.76	0.79	0.58	0.30	0.73	0.64	Upgrade
Inventory Turnover	3.53	3.78	6.98	1.48	2.20	1.48	Upgrade
Quick Ratio	0.81	0.78	1.81	0.39	2.69	2.90	Upgrade
Current Ratio	1.73	1.92	2.25	0.49	3.37	4.23	Upgrade
Return on Equity (ROE)	51.99%	-141.75%	-26.18%	-62.97%	-21.82%	-20.63%	Upgrade
Return on Assets (ROA)	18.73%	-5.80%	-12.53%	-18.13%	-7.78%	-5.34%	Upgrade
Return on Capital (ROIC)	32.66%	-7.23%	-14.57%	-28.80%	-10.19%	-6.73%	Upgrade
Return on Capital Employed (ROCE)	36.10%	-	-	-	-	-	Upgrade
Earnings Yield	2.15%	-130.21%	-5.10%	-6.43%	-2.77%	-9.26%	Upgrade
FCF Yield	0.14%	-36.53%	-3.13%	-7.38%	0.30%	0.23%	Upgrade
Buyback Yield / Dilution	-6.63%	-43.61%	-83.52%	-14.42%	-	-	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.